AOAbdulmojeed Aishat O

Abdulmojeed Aishat O

*This is an algorithmically generated author record based on publicly available information.

Abdulmojeed Aishat O has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehension, viewpoint and precautionary measures against covid-19 among pregnant women attending ante-natal care at a tertiary health facility in Abuja, Nigeria

    by Fatima Inusa Anga, Habeebah T. Bakare, Chris O. Ifediora, Halima Inusa Anga, Aminat Suleman-Alabi, Amina Ibrahim Shehu, Aisha Mukhtar Dodo, Shefa’ATu Shehu, Karima Abdulaziz, Aishat O AbdulMojeed, et al.

    Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). Pregnant women are particularly vulnerable to COVID-19 due to physiological and immunological changes in pregnancy. Understanding their knowledge and preventive practices is essential for guiding maternal-health interventions. This study assessed the knowledge, perceptions, and adoption of preventive measures against COVID-19 among pregnant women attending antenatal care at the Federal Medical Centre (FMC), Jabi, Abuja. A descriptive cross-sectional study was conducted from July to September 2021 among pregnant women selected through multistage sampling. Using a structured, interviewer-administered questionnaire we obtained data on knowledge, perceptions and preventive practices from 120 women participated. Data was analyzed using SPSS version 28 and summarized as descriptive statistics. Awareness of COVID-19 was high (95.8%) among pregnant women. Most respondents demonstrated adequate knowledge of transmission and prevention, including hand hygiene (99.2%), avoidance of crowds (92.5%), and isolation measures (90.0%). Misconceptions persisted, particularly regarding breastfeeding. Only 35.0% agreed that COVID-19 positive mothers can safely breastfeed, while 42.5% were unsure. Vaccine willingness was moderate (54.2%), reflecting hesitancy despite overall good knowledge. We found high level of awareness and generally positive preventive attitudes toward COVID-19 among pregnant women, but gaps remain in breastfeeding knowledge and vaccine acceptance. Targeted health education and strengthened ANC counselling are needed to address misconceptions and support consistent adoption of preventive practices.

  • Progress and Prospects in HIV Vaccine Development: A Comprehensive Review

    by Vivian Ukamaka Nwokedi, Comfort Ohunene Mathew, Enibokun Theresa Orobator, Ikechukwu Kanu, Olukunle O. Akanbi, Bankole Israel Adeyemi, Josephat Chisom Uzochukwu, Abdulmojeed Aishat O

    HIV/AIDS has been a disease condition affecting the entire world since its discovery in the 1980s, with over 38 million people in the globe living with the virus. Several attempts, research and funds have been channelled towards discovering a cure for HIV/AIDS yet no cure has been discovered. Considering the burden associated with the disease condition, having a vaccine to help control the spread will be a great approach in the course of achieving universal control coverage of the disease condition and an end to the disease over time. In this review we examined the progress, challenges, and future directions in HIV vaccine development and various types of vaccine candidates currently under investigation, highlighting key drug candidates that failed to provide protection against HIV such as PrEPVacc, HVTN 505, Uhambo (HVTN 702), Imbokodo (HVTN 705) and Mosaico (HVTN 706) as well as RV144 that provided 31.2% protection against HIV in a modified intent-to-treat analysis and those whose investigations are still in progress. The search for HIV Vaccine continues despite the modest success of some vaccines in clinical trials due to diversity in genetic nature of HIV, its ability to mutate rapidly, and the difficulty of eliciting a sustained immune response. Hence we also reviewed current approaches to improve on the success rate recorded by RV144.